Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
It is not approved for human or animal use and must not be incorporated into food, drugs, cosmetics, or diagnostic products
Rotator cuff pathology was the single largest injury category in the OnPeps BPC-157 dataset
GHK-Cu vs Adjacent Categories Format Topical GHK-Cu (cosmetic) What it is Copper Tripeptide-1 in serums and creams Evidence base Strongest human evidence (Leyden 2002, NEEL 2023) Typical use Daily anti-aging skincare Format Injectable GHK-Cu (research-use) What it is Reconstituted vial, SubQ injection Evidence base Mostly preclinical
